Stock Stories - Bamboo Works - China stock insights for global investors

Stories About 6185.HK

CanSino gets most of its revenue from meningitis shots

Meningitis shot delivers dose of good cheer for CanSino

2026-03-05

Founded in 2009 as a vaccine manufacturer, CanSino was listed on the Hong Kong Stock Exchange in March 2019 and on the Shanghai STAR Market in August 2020.

FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens

2024-04-30

CanSino Biologics announced on Tuesday it has entered into a grant agreement with the Bill & Melinda Gates Foundation, which will provide over $2 million to support development of the company’s recombinant poliomyelitis vaccine based on one of its virus-like particles.

FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine

2023-10-25

CanSino Biologics announced on Wednesday it recorded a net loss of 1.28 billion yuan in the first half of this year, reversing a 16.04 million yuan profit in the same period of 2022.

FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines

2023-08-31

Fosun Pharma, CanSino take different paths as Covid lift fade

2023-05-09

CanSino looks for next growth shot in ‘life after Covid’

2023-03-07

Discover hidden China stock gems in our weekly newsletter

Follow us

Subscribe to Our Free eNewsletter

Check out our content with some of our syndication partners